Mineralocorticoid receptor mediates heart failure in the 11ß-hydroxysteroid dehydrogenase type 2 transgenic mouse model

被引：0
|
作者：
Qin, WN
Bond, BR
Donoho, GP
Heyen, JR
Frierdich, GE
Bolten, CW
Funder, JW
McMahon, EG
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Pfizer Inc, St Louis, MO USA
[3] Pfizer Inc, Kalamazoo, MI USA
[4] Pfizer Inc, La Jolla, CA USA
[5] Prince Henrys Inst Med Res, Melbourne, Vic, Australia
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2946
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
  • [41] Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency
    Yau, Mabel
    Haider, Shozeb
    Khattab, Ahmed
    Ling, Chen
    Mathew, Mehr
    Zaidi, Samir
    Bloch, Madison
    Patel, Monica
    Ewert, Sinead
    Abdullah, Wafa
    Toygar, Aysenur
    Mudryi, Vitalii
    Al Badi, Maryam
    Alzubdi, Mouch
    Wilson, Robert C.
    Al Azkawi, Hanan Said
    Ozdemir, Hatice Nur
    Abu-Amer, Wahid
    Hertecant, Jozef
    Razzaghy-Azar, Maryam
    Funder, John W.
    Al Senani, Aisha
    Sun, Li
    Kim, Se-Min
    Yuen, Tony
    Zaidi, Mone
    New, Maria I.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (52) : E11248 - E11256
  • [42] Synthesis of sterically encumbered 11β-aminoprogesterone derivatives and evaluation as 11β-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists
    Pandya, Keyur
    Dietrich, David
    Seibert, Julia
    Vederas, John C.
    Odermatt, Alex
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (21) : 6274 - 6281
  • [43] Chenodeoxycholic acid and deoxycholic acid inhibit 11β-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor
    Stauffer, AT
    Rochat, MK
    Dick, B
    Frey, FJ
    Odermatt, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) : 26286 - 26292
  • [44] Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by organotins
    Nashev, LG
    Atanasov, AG
    Tam, S
    Baker, ME
    Odermatt, A
    FASEB JOURNAL, 2005, 19 (04): : A94 - A94
  • [45] Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2
    Ma, Xue
    Lian, Qing-Quan
    Dong, Qiang
    Ge, Ren-Shan
    TOXICOLOGY, 2011, 285 (03) : 83 - 89
  • [46] 11β-hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia
    Causevic, Maja
    Mohaupt, Markus
    MOLECULAR ASPECTS OF MEDICINE, 2007, 28 (02) : 220 - 226
  • [47] Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by MicroRNA
    Rezaei, Mina
    Andrieu, Thomas
    Neuenschwander, Samuel
    Bruggmann, Remy
    Mordasini, David
    Frey, Felix J.
    Vogt, Bruno
    Frey, Brigitte M.
    HYPERTENSION, 2014, 64 (04) : 860 - +
  • [48] Furosemide inhibits 11β-hydroxysteroid dehydrogenase type 2
    Fuster, D
    Escher, G
    Vogt, B
    Ackermann, D
    Dick, B
    Frey, BM
    Frey, FJ
    ENDOCRINOLOGY, 1998, 139 (09) : 3849 - 3854
  • [49] Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates
    Atanasov, AG
    Tam, S
    Röcken, JM
    Baker, ME
    Odermatt, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) : 257 - 262
  • [50] 11β-Hydroxysteroid dehydrogenase-type 2 evolved from an ancestral 17β-Hydroxysteroid dehydrogenase-type 2
    Baker, Michael E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 399 (02) : 215 - 220
12345